mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.01 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |